Common Diabetes Meds Tied to Serious COVID-19 Complication
TUESDAY, Jan. 12, 2021 (HealthDay News) — Diabetics who’ve contracted COVID-19 should suspend their use of a class of common diabetes drugs known as sodium-glucose co-transporter 2 inhibitors (SGLT2i), new research warns. People using these medications for diabetes are at risk of a potentially fatal complication called diabetic ketoacidosis (DKA),Continue Reading